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Abstract
Background: Pneumonia is an infection with the highest mortality rate in Indonesian hospitals. According to The American Thoracic Society and The Infectious Diseases Society of America (ATS/IDSA), empirical use of antibiotics is still effective for pneumonia treatment.  Inappropriate use of antibiotics would cause negative effects such as prolonged hospitalization, a high cost of treatment, and increased antibiotic-resistant bacteria. The goal of this study was to clarify the empirical use of antibiotic conformity with a bacteria culture. 
Methods: This study was conducted  from August to October 2013 using a descriptive retrospective method based on 116 medical records of pneumonia patients  hospitalized in Melati Ward, Dr. Hasan Sadikin General Hospital Bandung during 2011–2012. The type of bacteria, conformity with antibiotics given to patients, and type of antibiotics were analyzed. The conformity of antibiotics was assessed based on the resistance test. If the results were sensitive, they would be put in the conforming group and in the non-conforming group if the results were resistant or intermediate. Data was derived with descriptive statistics, using percentage 
and frequency distribution, illustrated in tables and figures.
Results: Based on culture results and sensitivity of antibiotic empirical therapy given, 55.17% cases were conformed. The most widely used antibiotic group was Third-generation Cephalosporin (60.34%). The most common bacterias were Klebsiella pneumonia (34.5%) and Acinetobacter baumanni (13.8%).
Conclusions: Most of the antibiotics given to pneumonia patients are still appropriate with  results of the bacteria culture test and  resistance test. [AMJ.2016;3(4):504–8]
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Introduction
Pneumonia is the inflammation of the distal parenchyme lung from terminalis bronchioles; it also includes respiratory bronchiolus, which 
causes lung tissue consolidation and the filling 
of alveoli by the inflammation exudate and the 
fibrin.1Pneumonia is still a severe problem with high morbidity and mortality.2,3 There are a wide variety of bacteria that cause pneumonia, depending on how pneumonia is transmitted. Pneumonia infections have the highest mortality rate in Indonesian hospitals.4 Antibiotics are used to treat pneumonia. 
Around 80−90% of antibiotics are used as 
treatment and prophylaxis for infection in clinics and hospitals, contributing to antibiotic resistance and one of the causes of the high mortality rate.5,6 According to the guidelines from The American Thoracic Society and the Infectious Diseases Society of America, empirical use of antibiotic is still effective to treat pneumonia.2 Whenever the patient had been diagnosed of pneumonia, they have to be hospitalized to be given the appropriate antibiotic empirical therapy.7−9 The inappropriate use of antibiotics causes negative consequences such as prolonged hospitalization, a high cost of treatment, and increased antibiotic resistance in bacteria.10Therefore, the goal of this study was to 
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clarify the conformity results of antibiotics with the bacteria culture in hospitalized pneumonia patients in Melati Ward at Dr. Hasan Sadikin General Hospital, Bandung from 2011–2012.   
MethodsThis study was conducted during August–October 2013 and used a descriptive retrospective method. The population of the study was all medical records of pneumonia patients who were hospitalized in Melati Ward representing the Internal Medicine Department at Dr. Hasan Sadikin General Hospital, Bandung during 2011–2012. Pneumonia was 
defined based on chest radiography  proof of 
a new pulmonary infiltrate, and at least two of the following symptoms and signs. There were cough, pleuritic chest pain, shortness of breath, temperature >38ºC, and crackles on auscultation.10 Medical records from this study subjects served as the secondary data. Data was collected by used of the total sampling method. The samples were all subjects that had the complete data and all the variables. Furthermore, the type of bacteria, their conformity with antibiotics given to the patients, and type of antibiotics were analyzed variables in this study.The inclusion criteria were medical records of hospitalized patients  with a diagnosis of pneumonia that had gone through the 
sensitivity test culture and were given medicine as written in the medical records. While medical records with incomplete data 
were excluded. Out of 478 medical records of pneumonia patients, only 116 medical records met the inclusion criteria. 
Next, the conformity was grouped into a conforming and non-conforming group. The conformity of antibiotics was assessed based on the resistance test. If the results were sensitive, they would be put in the  conforming group and in the non-conforming group if the results were resistant or intermediate.Moreover, data was derived with descriptive statistics, using percentage and frequency 
calculations by the Microsoft Excel software (Version 2010); the results of the study were 
illustrated in tables and figures.This study had been approved by the Health Research Ethics Committee, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital. 
ResultsOf the 116 patients who were given antibiotics, 55.17% were given the antibiotics that conformed with the bacteria culture test. The antibiotics that were appropriate with the gram-negative bacteria were 53.25%, while 59.46% were appropriate with gram-positive bacteria and 50% for the other bacteria (Figure 1).The predominantly used antibiotic groups 
Figure 1 Bacteria Distribution and Resistance Test of Culture Results in Hospitalized 
    Pneumonia Patients at Melati Ward in Dr Hasan Sadikin Hospital Bandung 2011– 
    2012
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were Third-Generation Cephalosporin in 70 patients (60.34%), followed by Fluoroquinolone in 33 patients (28.45%). The antibiotic groups that were most appropriate were Third-Generation Cephalosporin (51.43%), followed by Fluoroquinolone (54.55%), based on the results of the resistance culture (Table 1).The antibiotic was given due to the sign and symptom from patients that indicated pneumonia. The use of broad-spectrum antibiotics was still used as an empirical 
therapy before the culture test was performed, 
to determine the definitive therapy.Furthermore, antibiotics given to the hospitalized Pneumonia patients were Ceftazidime 50/116 (43.1%), followed by 
Levofloxacin 26/116 (22.4%), Ceftriaxone 
10/116 (8.6%), Cefotaxim 9/116 (7.8%), 
Ciprofloxacin and Erythromicin 7/116 (6.0%) (Figure 2).The culture results of hospitalized pneumonia patients showed that the predominant type of bacteria was Gram 
Table 1 Antibiotic Groups Distribution and Resistance of Culture Results in Hospitalized  





n % n %Third-Generation Cephalosporin 36 51.43 34 48.57 70 60.34Fluoroquinolone 18 54.55 15 45.45 33 28.45Macrolide 6 85.71 1 14.29 7 6.03Carbapenem 2 100.00 0 0.00 2 1.72Penicillin 0 0.00 1 100.00 1 0.86Fourth-Generation Cephalosporin 1 100.00 0 0.00 1 0.86Second-Generation Cephalosporin 0 0.00 1 100.00 1 0.86Aminoglycoside 1 100.00 0 0.00 1 0.86
Σ 64 55.17 52 44.83 116 100
Figure 2 Distribution of Antibiotic Types Used on Hospitalized Pneumonia Patients at 
     Melati Ward in Dr Hasan Sadikin Hospital Bandung 2011–2012
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negative (-) bacteria (66.38%) (Figure 3).The predominant types of bacteria were Klebsiella pneumonia 40/116 (34.5%), followed by Acinetobacter baumannii 16/116 (13.8%) (Figure 4).
DiscussionsPneumonia can occur in the primary tissue of normal lung tissue or in abnormal lung tissue. It could also be an advanced phase of Acute Lower Respiratory Tract Infection. The etiology of pneumonia depends on the type of pneumonia. Bacteria characteristics that cause 
pneumonia depend on the patient’s context of 
exposure to pollution, immunity disturbance, 
and irrational use of antibiotics.1,11Based on the results of specimen cultures from this study, the predominant sources of Gram-negative bacteria were Klebsiella pneumonia, followed by Acinetobacter baumannii (13.8%). Only 6.0% were from the Gram-positive bacteria Staphylococcus aureus.12 A study about pneumonia prevalence in Asian Countries by Chung et al.6 in 2011, also stated the predominant causes of pneumonia are Acinetobacter spp (36.5%), Pseudomonas aeruginosa (25.9%), and Klebsiella pneumonia (16.8%), all of which are Gram-negative bacteria; only 12.2% is caused by the Gram-positive bacteria Staphylococcus aureus. According to the 2007 guidelines of the 
Figure 3 Bacteria Distribution on Hospitalized Pneumonia Patients at Melati Ward in  Dr 
    Hasan Sadikin Hospital Bandung 2011–2012
Figure 4 Distribution of Pneumonia Bacteria Type in Hospitalized Pneumonia Patients at  
    Melati Ward in Dr Hasan Sadikin Hospital Bandung  2011–2012
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Infectious Disease Society of Taiwan on the use of antibiotics for pneumonia, infections of Klebsiella pneumonia, Sterptococcus pneumoniae, Pseudomonas aeruginosa and Acinetobacter spp are best treated with Third-generation cephalosporin (or Fluoroquinolone as the alternative).13 In this study, 70 out of 116 patients (60.34%) were given Third-generation cephalosporin antibiotics, and 33 out of 116 (28.45%) patients were given 
fluoroquinolone. The results showed that the empirical use of antibiotics on the Pneumonia patients supported the guidelines from the Infectious Disease Society of Taiwan.13It is important to consider, giving ceftazidime for the empirical treatment of hospitalized pneumonia patients is equivalent in term of 
efficacy and is well tolerated. Nevertheless, 
the use of fluroquinolone needs a tighter supervision to prevent the complication that might happen or the treatment can be substituted with tigecycline as an alternative.14The empirical antibiotic therapy should be considered with the condition of the patients, monitoring of microbial pathogens and bacterial resistance are possible things to avoid bacterial resistance.15This study had several limitations. First, data were obtained only from one hospital; 
this might not reflect the overall antibiotics conformity. Also, there were some missing data from the medical records.In conclusion, most of the empirical use of antibiotics are still appropriate. The most given antibiotics  are Third-generation Cephalosporin and Fluoroquinolone group, 
which are Ceftazidime and Levofloxacin. Based on this study, the prominent bacteria that caused pneumonia was Gram Negative (-) Bacteria, which were Klebsiella pneumonia and Acinetonacter baumannii. Therefore , 
Ceftazidime and Levofloxacin can still be used as the empirical antibiotics in Dr. Hasan Sadikin General Hospital.
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